The FDA has approved for marketing the BrainPort V100 (Wicab, Inc.) device to help orient blind people by helping them process visual images with their tongues, when used with other assistive devices (eg, cane, guide dog).
The Food and Drug Administration (FDA) has determined that the Boxed Warning for Potiga (ezogabine; GlaxoSmithKline) is adequate to manage the potential risks of vision loss due to pigment changes in the retina and skin discoloration.
Real-time ultrawide field retinal imaging has high sensitivity, specificity for detecting referable DR
Featured courses from mycme
Among the many issues clinicians face today, staying current with advances in medicine is becoming ...
Blurred vision - Red flag symptoms
This module reviews all topics on the NCCPA examination blueprint relating to Pulmonology, Ophthalmology, and ...
- Risks and Recommendations: The Use of NSAIDs in Patients With Cardiovascular Disease
- Paleo Diet: Should It Stay in the Stone Age?
- Neurological Complications Caused by "Skinny Jeans"
- What's the Secret to Longevity? Lessons from "Blue Zones" Worldwide
- Popular Restaurant Meals That Pack a Caloric Punch